Unmeasurable stimulated thyroglobulin before radioactive iodine ablation predicts excellent long term outcome in patients with differentiated thyroid cancer

被引:0
|
作者
Sia, Yi
Patel, Neil
De Jong, Mechteld
Khan, Shad
Mihai, Radu
机构
关键词
D O I
10.1093/bjs/znac056.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Experiences of low iodine diets in the treatment of differentiated thyroid cancer with radioactive iodine ablation therapy
    Herbert, Georgia
    Searle, Aidan
    England, Clare Yvonne
    Ness, Andy
    Beasley, Matthew
    Haupt-Schott, Ingrid
    Moss, Laura
    Wescott, Judith
    Atkinson, Charlotte
    CLINICAL NUTRITION ESPEN, 2020, 39 : 190 - 197
  • [22] Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
    Mei, Xiaoran
    Yao, Xiaoqin
    Feng, Fang
    Cheng, Weiwei
    Wang, Hui
    BMC CANCER, 2021, 21 (01)
  • [23] Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
    Xiaoran Mei
    Xiaoqin Yao
    Fang Feng
    Weiwei Cheng
    Hui Wang
    BMC Cancer, 21
  • [24] Prediction of radioactive iodine remnant ablation failure in patients with differentiated thyroid cancer: A cohort study of 740 patients
    Prpic, Marin
    Kust, Davor
    Kruljac, Ivan
    Kirigin, Lora Stanka
    Jukic, Tomislav
    Dabelic, Nina
    Bolanca, Ante
    Kusic, Zvonko
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (01): : 109 - 115
  • [25] Long-Term Consequence of Elevated Thyroglobulin in Differentiated Thyroid Cancer
    Yim, Ji Hye
    Kim, Eui Young
    Kim, Won Bae
    Kim, Won Gu
    Kim, Tae Yong
    Ryu, Jin-Sook
    Gong, Gyungyub
    Hong, Suck Joon
    Yoon, Jong Ho
    Shong, Young Kee
    THYROID, 2013, 23 (01) : 58 - 63
  • [26] Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer
    Hu, Tianpeng
    Meng, Zhaowei
    Zhang, Guizhi
    Jia, Qiang
    Tan, Jian
    Zheng, Wei
    Wang, Renfei
    Li, Xue
    Liu, Na
    Zhou, Pingping
    Upadhyaya, Arun
    MEDICINE, 2016, 95 (35)
  • [27] Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
    Jammah, Anwar A.
    Masood, Afshan
    Akkielah, Layan A.
    Alhaddad, Shaimaa
    Alhaddad, Maath A.
    Alharbi, Mariam
    Alguwaihes, Abdullah
    Alzahrani, Saad
    FRONTIERS IN ENDOCRINOLOGY, 2021, 11
  • [28] Response to Letter: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?
    Momesso, Denise P.
    Tuttle, R. Michael
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (06): : 2115 - 2116
  • [29] Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?
    Giovanella, Luca
    Cosma, Chiara
    Plebani, Mario
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (06): : 2113 - 2114
  • [30] Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer
    Saracoglu, Seray
    Guven, Osman
    Babacan, Gunduzalp Bugrahan
    Karyagar, Savas
    Ozulker, Tamer
    Ergur, Sadik
    Karyagar, Sevda Saglampinar
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 112 - 116